Dear Dr. Kelley, Allow me to introduce myself. My name is Roger Orlandi and I started in Flow Cytometry in Feb. 1998. My background was 22 years in Hematology, the las 17 as Supervisor. I moved into Flow Cytometry when an unexpected opening occurred just prior to the Hospital Laboratory and the next door Clinic Laboratory consolidated. Please subscribe me to your Cytometry Mailing List. Also, would you ask your members the following billing question. The question is in a two color panel of reagents using a marker more than one time with different other markers, is it justifiable to charge for the marker a second time. Example: in this 4 tube panel of CD3/CD19, CD5/CD19, CD10/CD19, and CD5/CD23 would this be correctly billed as CPT-88180 (X5) or would it be understandable and justifiable to bill CPT-88180 (X8). Being new to Flow Cytometry and relatively a novice in billing practices, I think that the significance of the co-expression of markers makes the (X8) understandable, but whether it is correct (lawful) or not, neither my Pathologist Director or other in-house billing people seem to have a knowledgeble answer. We have been currently billing the lower number of markers to be on the safe side. Any insite or information on acceptable billing practices in Flow Cytometry would be greatly appreciated. Sincerely, RSO rorlandi@inet.guthrie.org
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:52:56 EST